Price Chart

No data available
DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
             
             
             
             
             
             
             
             

Earnings

Next Report Date --
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date --
Beat/Miss Upgrade
Return Since --
Last FQE 12/31/2021
Next FQE 03/31/2022

Profile

Edit
Tauriga Sciences Inc is a revenue-generating company that operates through the development, distribution, and licensing of proprietary products as well as evaluation of potential acquisition opportunities. The firm has entered into the cannabidiol (or CBD) infused chewing gum product business. This CBD-infused chewing gum product has been branded under Tauri-Gum. The company commenced sales of Peach-Lemon and Black Currant CBG Gum. It operates in two segments: Tauri-gum division consists of all retail, wholesale, and e-commerce product sales of CBD/CBG Tauri-Gum, Tauri-Gummies, and other CBD/CBG products. Pharma segment includes research and development of the company's FDA IND application for Phase II Trial of its proposed pharmaceutical-grade version of Tauri-Gum.
URL https://www.taurigum.com
Investor Relations URL N/A
HQ State/Province New York
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style Small Cap/Value
Next Earnings Release N/A
Last Earnings Release N/A
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
-87.50%
220.0%
-82.81%
-99.66%
111.9%
169.7%
-73.70%
-81.31%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-19.50%
-87.17%
63.37%
16.67%
-79.93%
-17.17%
8.91%
-45.97%
-71.32%
-9.04%
-23.93%
70.05%
-17.52%
10.42%
-13.60%
-24.30%
-51.92%
-18.25%
-29.46%
-55.16%
-57.46%
-66.95%
321.7%
-47.71%
-67.81%
56.85%
-66.70%
-33.39%
-96.85%
-9.48%
-24.44%
-28.93%
-61.79%
As of October 04, 2022.

Profile

Edit
Tauriga Sciences Inc is a revenue-generating company that operates through the development, distribution, and licensing of proprietary products as well as evaluation of potential acquisition opportunities. The firm has entered into the cannabidiol (or CBD) infused chewing gum product business. This CBD-infused chewing gum product has been branded under Tauri-Gum. The company commenced sales of Peach-Lemon and Black Currant CBG Gum. It operates in two segments: Tauri-gum division consists of all retail, wholesale, and e-commerce product sales of CBD/CBG Tauri-Gum, Tauri-Gummies, and other CBD/CBG products. Pharma segment includes research and development of the company's FDA IND application for Phase II Trial of its proposed pharmaceutical-grade version of Tauri-Gum.
URL https://www.taurigum.com
Investor Relations URL N/A
HQ State/Province New York
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style Small Cap/Value
Next Earnings Release N/A
Last Earnings Release N/A
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

No data available
Symbol Dollars Invested % Weight
     
     
     
     
     
     
     
     
     
     

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter TAUG Tweets